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ABSTRACT
Background: Intravenous medication
administrations have a high incidence of error but
there is limited evidence of associated factors or error
severity.
Objective: To measure the frequency, type and severity
of intravenous administration errors in hospitals and
the associations between errors, procedural failures
and nurse experience.
Methods: Prospective observational study of 107
nurses preparing and administering 568 intravenous
medications on six wards across two teaching
hospitals. Procedural failures (eg, checking patient
identiﬁcation) and clinical intravenous errors (eg,
wrong intravenous administration rate) were identiﬁed
and categorised by severity.
Results: Of 568 intravenous administrations, 69.7%
(n¼396; 95% CI 65.9 to 73.5) had at least one clinical
error and 25.5% (95% CI 21.2 to 29.8) of these were
serious. Four error types (wrong intravenous rate,
mixture, volume, and drug incompatibility) accounted
for 91.7% of errors. Wrong rate was the most frequent
and accounted for 95 of 101 serious errors. Error rates
and severity decreased with clinical experience. Each
year of experience, up to 6 years, reduced the risk of
error by 10.9% and serious error by 18.5%.
Administration by bolus was associated with a 312%
increased risk of error. Patient identiﬁcation was only
checked in 47.9% of administrations but was
associated with a 56% reduction in intravenous error
risk.
Conclusions: Intravenous administrations have a higher
risk and severity of error than other medication
administrations. A signiﬁcant proportion of errors
suggest skill and knowledge deﬁciencies, with errors
and severity reducing as clinical experience increases.
A proportion of errors are also associated with routine
violations which are likely to be learnt workplace
behaviours. Both areas suggest speciﬁc targets for
intervention.
INTRODUCTION
Medication administration errors occur
frequently and are more likely to result in
serious harm and death than other types of
medication errors.
1 2 Direct observational
studies in hospitals have produced estimates
of administration error rates of around
19e27%
3e6 of drugs administered to
patients. Errors can have negative impacts for
both patients and nurses. A small proportion
of errors will lead to serious patient outcomes
and even minor errors can leave long-lasting
effects on the nurses involved.
78
Intravenous medications pose particular
risks because of their greater complexity and
the multiple steps required in their prepara-
tion, administration and monitoring. Rela-
tively few studies have speciﬁcally focused on
intravenous medication administration
errors, but those available conﬁrm their high
error rates (49%
9 48%
10 81%
11), with the
exception of one Australian study which
reported an intravenous error rate of 18% of
continuous infusions among surgical
patients.
12
Serious patient outcomes are over-repre-
sented among intravenous medication
administration errors compared with other
adverse incidents.
13 In 2007 in the UK, 62%
of voluntarily reported incidents nationwide
which led to death or severe patient harm
involved intravenous administrations.
1
Research from the USA has also shown that
intravenous medication errors have a signiﬁ-
cantly higher rate of associated deaths than
other medication errors.
2
Limited detailed analysis of the speciﬁc
types of errors which occur in intravenous
medication administrations, or those
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Original researchassociated with the most severe outcomes, has occurred.
Further, investigations of speciﬁc nurse characteristics or
the relationship between compliance with recognised
administration practices and intravenous error rates are
rare, and reduce the potential to develop effective
interventions.
This aim of this study was to measure the frequency,
type and severity of intravenous medication administra-
tion errors in hospital and assess the associations between
errors, procedural failures and nurse experience.
METHODS
Sample
The study was undertaken at two major teaching hospi-
tals in Sydney, Australia, located 40 miles apart. The
authors undertook direct observation of 107 nurses, 53
across four wards in Hospital A (400 beds) and 54 nurses
across two wards at Hospital B (326 beds) as they
prepared and administered medications.
The study wards had an average of 28 beds and
included geriatrics, respiratory, renal/vascular, ortho-
paedics and neurology, and had both surgical and
medical patients. Data were collected at Hospital A
between September 2006 and February 2007 (340 h of
direct observation) and at Hospital B between November
2007 and March 2008 (164.75 h).
This paper reports analysis of 568 intravenous medi-
cation administrations which were a subset of data from
a larger study of all types of medication administrations.
3
Human research ethics approval was received from both
hospitals and the University of Sydney.
Procedures
Nurses were invited to participate and were informed
that the aim of the study was to identify errors in
the preparation and administration of medications.
Eight-four per cent (107/126) of nurses participated.
Researchers arrived on the wards at the peak medication
administration times (07:00e21:30) and shadowed indi-
vidual nurses who had provided consent. Observers were
instructed in a ‘serious error’ protocol which allowed
them to intervene if they witnessed an administration
which was potentially dangerous. This occurred 10 times.
A structured observational tool
14 was developed and
incorporated into software on a handheld computer
(personal digital assistantdPDA) Further details of this
method have been reported elsewhere.
14 Figure 1 shows
the data collection software with the list of the proce-
dures (see also box 1 for deﬁnitions) which are checked
during the observation and the details recorded for each
drug administered. During observations researchers
recorded medication administration procedures and
details of the medications administered, such as drug,
dose and route (researchers did not view patients’
medication charts during observations). Years of nursing
experience for each participant were also recorded.
Box 1 lists and deﬁnes the procedures that were
observed. Compliance with all procedures included in
the study is required practice by nurses working in public
hospitals in the state of New South Wales. To determine
the rate of bolus injections we used an inbuilt timer in
the PDA. The observer viewing a bolus injection would
press ‘start’ when the nurse begins injecting the drug
(disregarding any line ﬂushing), and press ‘stop’ when
the nurse stopped the administration. For assessing the
rate of intravenous infusions the observer would record
the infusion pump rate or count the number of drops
per minute delivered by the administration set along
with noting the type of administration set used, that is,
standard macro set 20 drops/min or paediatric set
60 drops/min.
All observers (n¼3) were registered nurses or doctors
and trained in the use of the tool and data deﬁnitions.
Inter-rater reliability was calculated by two researchers
independently observing the same nurse and then
comparing agreement between data elements. Inter-
rater reliability tests for 16 observation sessions produced
Kappa scores
16 of 0.94e0.96 showing high levels of
agreement. Observers were trained to be physically
close to study participants (approximately within 1 m) to
allow them to determine, for example, whether the
nurse checked the medication label prior to adminis-
tration. Thus establishing good rapport and trust was
essential. This was achieved by observers undertaking
Figure 1 Personal digital assistant data collection tool.
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weeks with nurses prior to formal data collection so that
they became comfortable with the observers’ presence
and accustomed to being studied.
Classiﬁcation of error type and severity
Procedural failures (box 1) were identiﬁed at the time of
observation. Identiﬁcation of clinical errors required
a review to assess if preparation was in accordance with
the Australian Injectable Drugs Handbook
15 and obser-
vational data to be compared with each patient’s medi-
cation chart to determine whether the medication
administered differed from the order. This process
involved a clinical pharmacist and an experienced nurse,
both independent of the study hospitals. Box 1 provides
the deﬁnitions of the four intravenous-speciﬁc error
types which were the focus of analysis.
The severity of clinical errors was classiﬁed by two
researchers using a ﬁve-point scale
17 (table 1).
Disagreement was settled by consensus and a clinical
pharmacologist consulted when required. A panel was
established to review the most serious errors and
a random selection of other errors.
Analyses
We calculated rates of procedural failures, clinical errors
and serious errors using total number of drug adminis-
trations(ie,totaldosesadministered)asthedenominator.
Each drug administration could be associated with none
or multiple procedural failures and/or clinical errors. We
conducted univariate analyses to identify factors associ-
ated with error rates. To assess the association between
nurse experience and error we used multivariable logistic
regression. We created two continuous variables from
yearsofexperiencewithestimatedtrendchangeat6 years
in the following way: inexperienced (<6 years)¼min
(experience, 6), experienced ($6 years)¼max(0, expe-
rience-6). Various trend change points were tested;
however, 6 years produced the best model ﬁt.
In these models the outcomes of interest were,
respectively, risk of at least one clinical error and risk of
serious error. The explanatory factors included nurse
experience, intravenous administration type (infusion or
bolus), patient identiﬁcation procedure and hospital.
We removed hospital from the models as the hospitals
differed with respect to the variable of interest, experi-
ence. We included interaction terms but removed them
when they failed to reach signiﬁcance, which was set at
p¼0.05.
RESULTS
Procedural failures
At least one procedural failure was recorded for 73.9% of
568 intravenous medication administrations (table 2).
Box 1 Deﬁnitions of procedural failures and intravenous-speciﬁc clinical error types
Procedural failures
- Failure to read medication label
- Failure to check patient identiﬁcation (Failure of nurse to check the patient’s identiﬁcation (wrist band OR asking the patient’s
nameanddateofbirth)withtheidentiﬁcationdetailsonthemedicationchartthenurseisusing,priortoadministeringthedose.)
- Temporary storage of medication in unsecure environment, for example at the nurses’ station
- Failure to record medication administration on medication chart
- Non-aseptic technique (observation of gross breaches of aseptic technique eg, not washing hands before preparation of
injection)
- Failure to check pulse/blood pressure before administration (when applicable)
- Failure to check blood sugar level prior to administering insulin
- Failure of two nurses to sign the dangerous drug register (applicable for dangerous drugs*)
- If intravenous medication:
e Failure of two nurses to check preparation
e Failure of two nurses to witness administration of a dangerous drug
Failure of two nurses to sign medication chart (applicable for dangerous drugs)
Clinical intravenous errors
Wrong intravenous rate: administration of intravenous drug at a faster rate than recommended in the Australian Injectable
Drugs Handbook (AIDH).
15 Administration of intravenous bolus or intravenous infusion $15% faster than recommended.
Wrong mixture: use of a solvent/diluent/additive that was incorrect according to the Australian Injectable Drugs Handbook
(AIDH).
15
Wrong volume: using a volume of diluent/solvent to prepare an injectable medication that differs from the Australian Injectable
Drugs Handbook (AIDH).
15
Drug incompatibility: one drug given with another drug or solution via the same intravenous infusion, or same bag, which is
NOT documented to be compatible. For example: frusemide and cefotaxime administered in combination.
*Some medications such as ‘drugs of addiction’ for example, opioids, are listed as ‘controlled’ substances (also known as
‘dangerous drugs’) according to legislation and regulations.
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compliance with all relevant procedures was low at
26.1%. Patient identiﬁcation was checked in less than
50% of all intravenous administrations.
Clinical intravenous errors
One or more clinical errors occurred in 396 (69.7%;
95% CI 65.9 to 73.5) intravenous administrations. Of
these, 25.5% (95% CI 21.2 to 29.8) were rated as serious
($3). No errors were rated ‘5’ as contributing to the
death of a patient. In total, 511 clinical errors were
identiﬁedd297 administrations had one error, 85 had
two, 12 had three, and two administrations had four
clinical errors.
Four error types (wrong mixture, wrong volume,
wrong rate or drug incompatibility) accounted for 91.7%
(n¼363) of all clinical errors, 99 of which were rated as
serious. The remaining errors were: wrong timing
(n¼31); wrong route (n¼1) and wrong drug (n¼1).
Hence 63.9% (363/568; 95% CI 60.0 to 67.9) of intra-
venous administrations had at least one of four intrave-
nous-related error types, which were the focus of the
following analyses. Wrong intravenous rate was the most
frequent error and most likely to be rated as serious
(table 3).
Intravenous error rates and serious error rates varied
by type of drug as shown in table 4. In the most frequent
type of drug administered, anti-infectives, two-thirds of
administrations had at least one error. Although used
infrequently, antiulcerants and antiemetics had very high
error rates (respectively 93% and 75%) and for anti-
emetics 44% were rated as serious. Type of drug was also
associated with different types of error (table 5).
Effects of intravenous administration type on errors and
severity
Intravenous administrations performed via bolus
(n¼312) had higher error rates than infusions (n¼256)
(77.2% vs 47.7%; c
2¼53.37, df¼1, p<0.0001) and also
higher serious error rates (23.4% vs 10.6%; c
2¼15.34,
df¼1, p<0.0001). For bolus intravenous infusions, all 72
serious errors involved incorrect rate, with nine also
involving wrong volume, wrong mixture or incompatible
drug. For intravenous infusions, wrong rate was involved
in 23 and wrong volume in 15 of 28 serious errors.
Inexperienced nurses incurred more errors in bolus
Table 1 Potential severity assessment code
17
Rating Description Categories used in analyses
1. Incident is likely to have little or no effect on the patient
2. Incident is likely to lead to an increase in level of care, for example, review,
investigations, or referral to another clinician
Minor errors
3. Incident is likely to lead to permanent reduction in bodily functioning leading to,
for example, increased length of stay; surgical intervention
Serious errors
4. Incident is likely to lead to a major permanent loss of function
5. Incident is likely to lead to death
Table 2 Compliance with required medication administration procedures
Procedure
Number of
administrations
complying
Number of
administrations where
procedure required
Percentage
compliance with
procedure (95% CIs)
Read medication label 552 568 97.2% (95.8 to 98.5)
Checked patient’s identiﬁcation 272 568 47.9% (43.8 to 52.0)
Used an aseptic technique 511 568 90.0% (87.5 to 92.4)
Recorded medication administration 530 568 93.3% (91.3 to 95.4)
Temporarily stored the medication prior
to administration
388 568 68.3% (64.5 to 72.1)
Two nurses checked the preparation of
a dangerous drug* or intravenous infusion
544 568 95.8% (94.1 to 97.4)
Two nurses witnessed the administration of
a dangerous drug
3 6 50.0% (10.0 to 90.0)
Two nurses signed the dangerous drug register 3 6 50.0% (10.0 to 90.0)
All relevant procedures complied with 148 568 26.1% (22.4 to 29.7)
*Some medications such as ‘drugs of addiction’ for example, opioids, are listed as ‘controlled’ substances (also known as ‘dangerous drugs’)
according to legislation and regulations.
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experience vs 71.2% for nurses $6 years (c
2¼6.15, df¼1,
p¼0.02)).
Use of infusion pumps
Infusion pumps were rarely used (17.6% of 256 infu-
sions). Use of a pump was not associated with a signiﬁ-
cant decrease in error rate (pump: 13.3% (6/45
infusions) vs no pump: 18.5% (39/211); c
2¼0.6790,
df¼1, p¼0.4099), nor serious error rate (pump: 83.3%
serious errors vs no pump: 46.2%; c
2¼2.8766, df¼1,
p¼0.0899). Nurses with <6 years experience were less
likely than experienced nurses to use an infusion pump
(9.3% vs 23.6%; c
2¼8.92, df¼1, p¼0.0028).
Nurse experience
The median nursing experience of the 107 nurses was
6 years (range <1e43 years). Logistic regression showed
that during the ﬁrst 6 years of nursing experience the
risk of error declined by 10.9% with each successive year
of experience (table 6). After this point, further expe-
rience provided no additional beneﬁt. Checking patient
identiﬁcation reduced error risk by 56%, while admin-
istration via intravenous bolus increased it by over 300%.
The risk of serious error declined by 18.5% per annum
during the ﬁrst 6 years of experience, with no additional
beneﬁt thereafter. Checking patient identiﬁcation
reduced risk of serious error, and administration via
intravenous bolus greatly increased the risk of serious
error (table 7).
DISCUSSION
Nearly 70% of all intravenous medications administered
had at least one clinical error, and a quarter of these
were serious errors likely to result in permanent harm to
patients. Few comparative studies are available. Direct
observational studies in the UK
9 and Germany
10
revealed overall error rates of 49% (212/430 intravenous
administrations) and 48% (58/122). A more recent
study of vancomycin intravenous administrations
reported a high rate of 81% (116/143 intravenous
administrations) in four wards in a hospital in Brazil.
11
An Australian study
12 of continuous infusions among
surgical patients reported an 18% error rate but
excluded infusions such as antibiotics. This drug group
was the most frequent in our study and may be one
reason for our rate differences. Only two studies
91 0
assessed error severity and used a 10-point scale
anchored at 0 no harm to 10 death. Severity categories
were collapsed into <3 (minor), 3e7 (moderate) and
>7 severe. In the UK study
9 1% of intravenous errors
Table 3 Type and severity of intravenous administration errors
Type of intravenous-related error Number of errors (%)
Number of errors rated as serious
(% of intravenous error type)
Wrong rate 266 (73.3) 95 (35.7)
Wrong volume 121 (33.3) 21 (17.4)
Wrong mix 21 (5.8) 5 (23.8)
Drug incompatibility 3 (0.8) 1 (33.3)
Total intravenous administrations
with at least one clinical error
363* 99* (27.3)
*Sums exceed totals because of multiple errors within the same intravenous administration.
Table 4 Type of drug by error rate
Drug group
Number of intravenous
administrations of this
drug type
Number of administrations
in drug group with at least
one intravenous error
(percentage in drug group)
Number of intravenous
errors rated as serious
(percentage in drug group)
Anti-infective 455 305 (67.0) 81 (26.6)
Antiemetic 24 18 (75.0) 8 (44.4)
Antiulcerant 15 14 (93.3) 3 (21.4)
Steroid 21 14 (66.7) 2 (14.3)
Diuretic 8 4 (50.0) 1 (25.0)
Anticoagulant 10 3 (30.0) 3 (100.0)
Narcotic 3 2 (66.7) 1 (50.0)
Other 7 2 (28.6) 0 (0.0)
Iron 8 1 (12.5) 0 (0.0)
Paracetamol 17 0 (0.0) 0
All drug types 568 363 (63.9) 99 (27.3)
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study 3% were severe and 31% moderate. Given the
differences in severity scales, our result of 25.5% serious
errors appears reasonably consistent with these ﬁndings.
A systematic review and Bayesian analysis of nine
studies of intravenous administration errors reported an
overall probability of at least one error in 73% of intra-
venous administrations.
18 This is similar to our ﬁnding
of at least one clinical error in 70% of administrations
observed. The analysis by McDowell et al
18 relied on data
from studies published between 1990 and 2006 (more
than half reﬂected data collected over 10 years ago).
When no data were available estimates were used. Few of
these previous studies collected detailed information
about procedural failures. For example, only two studies
in McDowell’s review collected information about
checking patient identiﬁcation and both reported no
errors. McDowell et al
18 reported that the reconstitution
step was the most error prone and that the checking of
patient identiﬁcation was the least. We found the
opposite. Factors such as the increased use of pre-
prepared injections, which is recommended practice in
New South Wales public hospitals, as part of contem-
porary medication administration practice may be one
reason for our lower error rate in this category.
Wrong administration rate has been shown consis-
tently to be the most signiﬁcant problem in intravenous
medication administration
9 12 19 20 consistent with our
ﬁnding. In an ethnographic study involving direct
observations and interviews with nurses, Taxis and
Barber
21 found wrong rate errors, particularly the fast
administration of bolus doses, were most frequently
direct violations where nurses reported deliberately
deviating from the correct rate. Concerns have also been
raised that a proportion of wrong rate errors are due to
poor calculation skills.
22 Poor supervision of junior
colleagues and a general lack of adequate training in
intravenous medication administration are further
contributors to error.
21
While infusion pumps have the potential to reduce
errors, their effectiveness in everyday practice is often
seriously compromised by a failure to use devices as
intended, for example by-passing safety features and
ignoring alerts.
23 24 We found a low utilisation of pumps
especially among less experienced nurses, the group
with the highest error rate. However, use of pumps was
not associated with reduced errors. The extent to which
this was due to incorrect use is unknown.
Few studies have examined the association between
nurse experience and intravenous medication errors. We
found that as nurses gained experience up to 6 years,
their rates and severity of errors declined signiﬁcantly.
This is an important ﬁnding and clearly suggests that
inexperienced nurses should be a target for training and
supervision with a focus on correct intravenous rates.
Han et al
12 found no relationship between experience
Table 5 Error type by drug group
Drug group
Total intravenous
administration errors
Frequency of error type* (percentage in drug group)
Wrong
rate
Wrong
volume
Wrong
mix
Drug
incompatible
Anti-infective 305 225 (73.8) 109 (35.7) 7 (2.3) 0 (0)
Antiemetic 18 17 (94.4) 1 (5.6) 0 (0) 0 (0)
Antiulcerant 14 8 (57.1) 0 (0.0) 12 (85.7) 3 (21.4)
Steroid 14 7 (50.0) 8 (57.1) 0 (0.0) 0 (0.0)
Diuretic 4 3 (75.0) 0 (0.0) 1 (25.0) 0 (0.0)
Anticoagulant 3 3 (100.0) 1 (33.3) 1 (33.3) 0 (0.0)
Narcotic 2 2 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Other 2 0 (0.0) 2 (100.0) 0 (0.0) 0 (0.0)
Iron 1 1 (100.0) 0 (0.0) 0 (0.0) 0 (0.0)
Paracetamol 0 0 0 0 0
All drug types 363 266 (73.3) 121 (33.3) 21 (5.8) 3 (0.8)
*Sums exceed totals due to multiple errors within the same intravenous administration.
Table 6 ORs from ﬁnal model for risk of at least one intravenous clinical error
Parameter OR (95% CI) p Value
Effect of nurse experience per annum up to 6 years 0.891 (0.810 to 0.980) 0.0176
Effect of nurse experience per annum at 6 years and over 1.009 (0.982 to 1.038) 0.5146
Intravenous administration typedbolus 4.115 (2.818 to 6.008) <0.0001
Patient identiﬁcation checked 0.439 (0.299 to 0.646) <0.0001
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sample was vastly more experienced (median 18 years)
compared with our study (median 6 years).
We found a signiﬁcant relationship between failing to
check a patient’s identiﬁcation and making an intrave-
nous administration error. While failing this check does
not cause a clinical error, we hypothesise that it is an
indicator of a general failure to follow correct adminis-
tration protocols, whether this is because the nurse is
under stress, time pressures, or selects to not comply.
This ﬁnding suggests that this variable could be used as
a proxy measure for increased risk of clinical error, and
interventions which reinforce compliance with adminis-
tration protocols may be effective in reducing clinical
errors. The poor compliance found with checking
patients’ identiﬁcation (47.9%) suggests that this is
a routine violation
25 performed by a large proportion of
nurses.
We used an undisguised observational technique and
nurses were aware that our study was investigating
problems in medication administration procedures and
errors. It is possible that nurses changed their behav-
iours when observed. The outcomes of this possible bias
would be to lead to an underestimation of the ‘true’
error and procedural failure rates. The length of the
study, which involved researchers being on the wards for
many months, reduces the likelihood of sustained
behaviour change by nurses on busy hospital wards.
Further, observational studies of clinicians in situ have
suggested that the extent of behaviour change is
minimal.
26 27 For example, Dean Franklin and Barber
28
found no difference in the rate of omitted medication
doses when nurses in a UK hospital were observed versus
those times when they were not. Our sample also only
relates to Australian nurses and thus may not be gener-
alisable to countries with very different nursing practice.
Our ﬁndings suggest that a signiﬁcant proportion of IV
administration errors reﬂect knowledge and/or skill
deﬁciencies, with errors reducing in the ﬁrst few years
of clinical experience. A proportion of errors are also
associated with routine violations
25 which are likely to be
learnt workplace behaviours which persist regardless
of increased clinical experience. Both areas suggest
speciﬁc targets for intervention. Such interventions could
include more training and supervision of new nurse
graduates and consideration of a reduced use of bolus
intravenous infusions. Raising nurses’ awareness of the
high intravenous administration error rate is also likely to
be helpful in reinforcing compliance with correct proce-
dures. Nurses receive very limited feedback of outcome
data about performance and the nearly total absence of
studies on this topic in the last 5 years is likely to have
contributed to its low proﬁle as an important safety issue.
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